Fear Blurs Danger and Safety in the Brain
A Nature Neuroscience paper shows how overlapping fear and safety memories in mice speed up their reactions to danger.
Global Diseases News
For readers following diseases, this page covers diagnosis, treatment breakthroughs and public health impact. Reporting follows emerging clinical research, international health alerts and disease risk studies.
COVID-19
Live Poll
Should your government keep funding costly vaccine research during future global health emergencies?
COVID Vaccines Returned $60 to $809 Per Dollar Invested
A study of 173 countries found high-income nations captured the largest economic gains from early vaccine access.
Asthma
Zelenskyy Says Drones Can Monitor Ceasefires
The Ukrainian president said drone and video surveillance can verify compliance without a buffer zone, citing a recent ceasefire in Oleshky.
Alzheimer’s
UNESCO Honors Nancy Ip for Alzheimer's Research
The international life sciences prize recognizes Ip's biomarker discoveries and blood tests aimed at earlier Alzheimer's diagnosis.
Stroke
Live Poll
Would you trust a doctor's advice to switch cholesterol medicines after a stroke?
PCSK9 Inhibitors May Be Safer Than Statins
A UCLA analysis suggests the cholesterol drugs may carry lower haemorrhagic stroke risk for some patients.
Diabetes
Trial Patients Show Less Activity, More Fibrosis
Researchers report that patients screened for MASH trials now present with less disease activity but more advanced liver scarring.
More in Diseases
Day to day, that means monitoring outbreaks, new treatment pathways, diagnostic innovations and the results of large-scale clinical trials. It reaches every region and institution where medical data is generated or public health policy is set. Public health initiatives must navigate diverse regulatory environments, which creates a pattern of staggered global adoption for new therapies. Availability of care and diagnostic infrastructure are the two primary constraints that define how these events unfold in practice.